Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Jan Tjeerd de Faber, WOC 2018 – Explosive Eye Injuries and SOE 2019

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jul 19th 2018

Jan Tjeerd de Faber, current President of SOE, introduces the key aims of SOE. This year SOE are conducting a survey of firework-related eye injuries, and how these injuries can be prevented. Every year hundreds of people are blinded by consumer fireworks, and data from 25 countries show that this is an underestimated cause of preventable blindness. SOE advocate professional fireworks and a ban on consumer fireworks and promote.

Dr Tjeerd de Faber welcomes ophthalmologists to attend SOE 2019, taking place in Nice, France, 13-16 June.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup